LGVN (STOCKS)
Longeveron Inc. Common Stock
$0.805800
+0.023200 (+2.96%)
Prev close: $0.782600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stephen H. Willard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.08M
- Employees
- 25
- P/E (TTM)
- -0.68
- P/B (TTM)
- 1.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.19 | $-0.17 | -0.0217 | -12.89% |
|
Dec 2025 (Q4)
|
$-0.23 | $-0.42 | +0.1933 | +45.67% |
|
Sep 2025 (Q3)
|
$-0.39 | $-0.26 | -0.1299 | -49.94% |
|
Jun 2025 (Q2)
|
$-0.33 | $-0.36 | +0.0296 | +8.23% |
Financial Statements
| Assets | $21.21M |
| Current Assets | $16.86M |
| Noncurrent Assets | $4.36M |
| Fixed Assets | $1.65M |
| Intangible Assets | $2.24M |
| Other Non-current Assets | $466.00K |
| Liabilities | $5.18M |
| Current Liabilities | $4.35M |
| Accounts Payable | $293.00K |
| Other Current Liabilities | $4.05M |
| Noncurrent Liabilities | $838.00K |
| Equity | $16.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $16.03M |
| Liabilities And Equity | $21.21M |